Krystal Biotech, Inc. (KRYS) stock
KRYSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 11/3052% above fair value
$298.55+0.65 (+0.22%)
Close on Nov 17, 2026Market cap $8.84BP/E 37.4Yield –
Krystal Biotech EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Krystal Biotech's EV/EBITDA was 41.9× on Nov 11, 2026, against 35.3× a year earlier. Over the last 2 years it ranged from 25.7× to 184.4×, with a median of 45.5×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 41.9× | +1.4 |
| 2025 | Dec 31, 2025 | 40.5× | −101.4 |
| 2024 | Dec 31, 2024 | 141.9× | – |
See a number that looks wrong?